Punna Rao Ravi

Punna Rao Ravi

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
PRPunna Rao Ravi
Punna Rao Ravi
NAN. Aditya
N. Aditya
HKHimanshu Kathuria
Himanshu Kathuria
SMSrinivas Malekar
Srinivas Malekar
RVRahul Vats
Rahul Vats

29 November 2013 in Drug Delivery
Verified
Journal Article
Closed access
PRPunna Rao Ravi
Punna Rao Ravi
NAN. Aditya
N. Aditya
SPS. Patil
S. Patil
LCL. Cherian
L. Cherian
Intranasal thermosensitive gel for rasagiline mesylate (RM) was developed for effective treatment of Parkinson's disease. Intranasal gels were prepared by combination of poloxamer 407 and poloxamer 188 (1:1) with mucoadhesive polymers (carbopol 934 P and chitosan). The formulations were evaluated for sol-gel transition temperature, in-vitro drug release and in-vivo mucociliary transit time. Further, optimal intranasal gel formulations were tested for in-vivo pharmacokinetic behavior, nasal toxicity studies and brain uptake studies. It was found that optimal formulations had acceptable gelation temperature (28-33 °C) and adequate in-vitro drug release profile. Pharmacokinetic study in rabbits showed significant (p < 0.05) improvement in bioavailability (four- to six-folds) of the drug from intranasal gels than oral solution. Chronic exposure studies in Wistar rats showed that these intranasal gels were non-irritant and non-toxic to rat nasal mucosa. Estimation of RM in rat brain tissue showed significant (p < 0.01) improvement in uptake of RM form intranasal gel formulations than nasal solution.

1 October 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AMAditya Murthy
Aditya Murthy
PRPunna Rao Ravi
Punna Rao Ravi
HKHimanshu Kathuria
Himanshu Kathuria
RVRahul Vats
Rahul Vats

1 September 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
CUChandra Teja Uppuluri
Chandra Teja Uppuluri
PRPunna Rao Ravi
Punna Rao Ravi
ADAvantika V. Dalvi
Avantika V. Dalvi

31 May 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
AMAditya Murthy
Aditya Murthy
PRPunna Rao Ravi
Punna Rao Ravi
HKHimanshu Kathuria
Himanshu Kathuria
SMShrinivas Malekar
Shrinivas Malekar
Raloxifene hydrochloride (RLX) shows poor bioavailability (90%). The objective of this study was to develop nanostructured lipid carriers (NLCs) for RLX to enhance its bioavailability. The NLC formulations were produced with glyceryl tribehenate and oleic acid. The particle characteristics, entrapment efficiency (EE), differential scanning calorimetry (DSC), in vitro drug release, oral bioavailability (in rats) and stability studies were performed. The optimized nanoparticles were 120 ± 3 nm in size with positive zeta potential (14.4 ± 0.5 mV); % EE was over 90% with the drug loading of 5%. The RLX exists in an amorphous form in the lipid matrix. The optimized RLX-NLC formulation showed sustained release in vitro. The RLX-NLC significantly (p < 0.05) enhanced oral bioavailability 3.19-fold as compared to RLX-free suspension in female Wistar rats. The RLX-NLC can potentially enhance the oral bioavailability of RLX. It can also improve the storage stability.

1 September 2020 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
RDRimpy Diwan
Rimpy Diwan
PRPunna Rao Ravi
Punna Rao Ravi
NPNikita Shantaram Pathare
Nikita Shantaram Pathare
VAVidushi Aggarwal
Vidushi Aggarwal